Stability Matters: Conjugate Stabilizers in LFA Development
In the competitive world of rapid diagnostics, a lateral flow assay (LFA) is only as good as its shelf life and stability. A test that performs perfectly in the lab but fails in the field after three months on the shelf is destined to lose customer trust.
One of the silent killers of LFA performance is conjugate instability. The gold nanoparticle-antibody conjugates used in the conjugate pad are highly sensitive to humidity, heat, and storage conditions. Without proper stabilization, they aggregate, lose binding activity, and compromise test performance.
At Prahas Healthcare, we recognize that stability is as critical as sensitivity. This is why we provide advanced conjugate stabilizers and consumables that ensure consistent kit performance across diverse geographies, from cold labs in Europe to humid warehouses in Africa.
Learn more about our stabilizers at www.prahashealthcare.com.
The Conjugate Challenge in LFA
Conjugates are the “engine” of lateral flow assays. When a sample enters the strip, the conjugate pad releases nanoparticles coated with antibodies, which bind to the target analyte. If these nanoparticles are aggregated or inactive, the test lines will appear weak or not at all.
Common Problems Without Stabilizers
- Nanoparticle Aggregation → clumping of gold particles leads to poor migration.
- Weak Test Lines → reduced sensitivity and false negatives.
- High QC Rejection Rates → manufacturers reject entire batches due to instability.
- Reduced Shelf Life → tests fail before reaching the customer.
The Role of Conjugate Stabilizers
Conjugate stabilizers are specialized formulations that:
- Prevent aggregation by maintaining nanoparticle dispersion.
- Protect antibodies from denaturation during drying and storage.
- Enhance signal intensity, making test lines clearer and sharper.
- Extend shelf life of diagnostic kits, even in challenging conditions (30–40°C).
�� Watch related process demonstrations on our YouTube Channel.
Prahas Healthcare’s Stabilizer Solutions
We offer stabilizers that have been field-tested in tropical regions. Key benefits include:
- +25–40% shelf life extension under real-time stability conditions.
- Improved reproducibility in test line clarity across lots.
- Compatibility with gold, latex, and fluorescent conjugates.
Our stabilizers are designed for bulk supply to manufacturers and can be tailored for specific assay chemistries.
Product details: www.prahashealthcare.com.
Real-World Case Study
A diagnostic manufacturer in Southeast Asia was struggling with short shelf life (6 months at 35°C). Kits were failing mid-distribution, leading to customer complaints. After integrating Prahas stabilizers into their workflow:
- Shelf life increased to 12 months at 35°C.
- QC rejection rates dropped by 60%.
- Their market expanded to Africa, where storage conditions are even harsher.
This transformation turned their business from local supplier to global exporter.
Why Stability is a Regulatory Priority
Agencies like ISO13485 and WHO PQ emphasize stability testing. Unstable kits:
- Fail accelerated and real-time stability studies.
- Increase risk of recalls.
- Damage brand reputation.
By using validated stabilizers, manufacturers not only protect their kits but also safeguard their regulatory compliance.
Conclusion
Stability is not just about product longevity — it is about customer trust and global competitiveness. Without stabilizers, even the best-designed assays risk failure in real-world conditions.
At Prahas Healthcare, our stabilizers are engineered to protect conjugates, improve test clarity, and ensure that your kits reach customers with confidence.
Contact us: +91 9824704223
Email: sales.exec@prahashealthcare.com | hasnain@prahashealthcare.com
Website: www.prahashealthcare.com
Learn more: YouTube Channel